Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new line reading '2023 ( U.S. NIH Grant/Contract )' was added to the study's funding/identifiers section, indicating NIH support for the trial. This addition provides funding attribution without altering the study design or participant information.
    Difference
    0.0%
    Check dated 2026-08-24T16:57:42.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Added related topics to the study record, including Multiple myeloma and MedlinePlus Genetics, to provide quick access to disease context and genetics resources.
    Difference
    0.1%
    Check dated 2026-08-17T13:45:12.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The page’s revision metadata was updated to v3.6.5, signaling a new version of the content. No study details or user-facing information appear to be altered.
    Difference
    0.0%
    Check dated 2026-08-10T10:27:33.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Removed the terms 'Multiple myeloma' and the related topics header 'MedlinePlus Genetics' from the page content. This changes labeling and navigation cues related to related topics without altering the study details.
    Difference
    0.1%
    Check dated 2026-08-03T06:36:08.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new disease navigation tag 'Multiple myeloma' and a 'related topics' section linking to MedlinePlus Genetics were added. The site revision was updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-27T06:17:58.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page no longer shows the term 'Multiple myeloma' and the 'related topics' section, along with the MedlinePlus Genetics link. This removes some disease context and related resources from the study details page.
    Difference
    0.1%
    Check dated 2026-07-20T01:26:39.000Z thumbnail image

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.